West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 387,700 | 382,300 | 376,700 | 388,000 | 362,100 |
| Cost of Goods | 253,500 | 258,600 | 255,600 | 254,700 | 238,800 |
| Gross Profit | 134,200 | 123,700 | 121,100 | 133,300 | 123,300 |
| Operating Expenses | 74,200 | 71,600 | 70,400 | 72,800 | 94,100 |
| Operating Income | 60,500 | 52,700 | 51,300 | 61,200 | 30,000 |
| Interest Expense | 2,100 | 1,400 | 2,200 | 2,000 | 2,500 |
| Other Income | 4,700 | 4,000 | 2,900 | 2,500 | 1,500 |
| Pre-tax Income | 63,100 | 55,300 | 52,000 | 61,700 | 29,000 |
| Income Tax | 2,200 | 16,100 | 14,400 | 17,000 | 6,900 |
| Net Income Continuous | 60,900 | 39,200 | 37,600 | 44,700 | 22,100 |
| Net Income | $60,900 | $39,200 | $37,600 | $44,700 | $22,100 |
| EPS Basic Total Ops | 0.83 | 0.53 | 0.51 | 0.61 | 0.31 |
| EPS Basic Continuous Ops | 0.83 | 0.53 | 0.51 | 0.61 | 0.30 |
| EPS Diluted Total Ops | 0.81 | 0.51 | 0.50 | 0.60 | 0.30 |
| EPS Diluted Continuous Ops | 0.81 | 0.52 | 0.50 | 0.60 | 0.30 |
| EBITDA(a) | $83,800 | $75,500 | $74,200 | $83,900 | $52,300 |